StocksFin Logo
InnovAge Holding Corp. country of incorporation
|
|
2,000 employees
NASDAQ | Healthcare | Medical Care Facilities
Zealand Pharma A/S country of incorporation
|
|
Dr. Emmanuel Dulac Ph.D., PharmD, MBA
|
237 employees
NASDAQ | Healthcare | Biotechnology
Q123 reported Nov 8, 2022 Reporting Period
$171.22M -1.1% vs. Q122 Revenues Q123
12.51% -48.8% vs. Q122 Gross Profit Margin
-7.64% ! -271.9% vs. Q122 Net Profit Margin
5.46M -73.4% vs. Q122 Free Cash Flow Q123
$-0.1 ! -266.7% vs. Q122 EPS Q123
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
Q122
Q122 reported Mar 31, 2022 Reporting Period
$15.08M -68.5% vs. Q121 Revenues Q122
80.69% 60.2% vs. Q121 Gross Profit Margin
-1000% ! -97.4% vs. Q121 Net Profit Margin
-320.75M ! 12.9% vs. Q121 Free Cash Flow Q122
$-5.16 ! 10.7% vs. Q121 EPS Q122
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
Q122
Loading...
Loading...
Ratios
As of
Dec 31, 2022
Mar 31, 2022
Quick Ratio
1.76
3.68
Current Ratio
1.88
4.79
Cash Ratio
0.94
3.4
Price to Book
3.12
6.04
Price to Sales
5.81
100
Price to Earnings
-24.85
-4.81